Drug name - Qbrelis

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9616096 AZURITY Lisinopril formulations Nov, 2035

(13 years from now)

US10039800 AZURITY Lisinopril formulations Nov, 2035

(13 years from now)

US10406199 AZURITY Lisinopril formulations Nov, 2035

(13 years from now)

US10265370 AZURITY Lisinopril formulations Nov, 2035

(13 years from now)

US9463183 AZURITY Lisinopril formulations Nov, 2035

(13 years from now)

US11179434 AZURITY Lisinopril formulations Nov, 2035

(13 years from now)

US10940177 AZURITY Lisinopril formulations Nov, 2035

(13 years from now)

US9814751 AZURITY Lisinopril formulations Nov, 2035

(13 years from now)

Drugs and Companies using LISINOPRIL ingredient

Treatment: Treatment of hypertension; method of treating hypertension; treatment of heart failure; treatment of myocardial infarction; reduction of mortality in acute myocardial infarction; acute myocardial infarction; method of treatment of heart failure; Acute myocardial infarction; treatment of myocardial infarction; reduction of mortality in acute myocardial infarction; method of treatment of heart failure; treatment of heart failure; treatment of hypertension; method of treating hypertension; Treatment of myocardial infarction; method of treating hypertension; treatment of heart failure; method of treatment of heart failure; reduction of mortality in acute myocardial infarction; treatment of hypertension; acute myocardial infarction

Dosage: SOLUTION;ORAL

More Information on Dosage
Strength Dosage Availability
1MG/ML SOLUTION;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.